Low regulatory T-cells: A distinct immunological subgroup in minimal change nephrotic syndrome with early relapse following rituximab therapy
10.1016/j.trsl.2021.03.019
Saved in:
Main Authors: | CHAN CHANG YIEN, SHARON TEO SHER LEEN, Lu Liangjian, CHAN YIONG HUAK, LAU YEW WENG PERRY, MYA THAN, Jordan C Stanley, LAM KONG PENG, NG KAR HUI, YAP HUI KIM |
---|---|
Other Authors: | PAEDIATRICS |
Format: | Article |
Language: | English |
Published: |
Elsevier Inc.
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/200314 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Language: | English |
Similar Items
-
T Lymphocyte Activation Markers as Predictors of Responsiveness to Rituximab among Patients with FSGS
by: CHAN CHANG YIEN, et al.
Published: (2021) -
SARS-CoV-2 Humoral Immunity Persists Following Rituximab Therapy
by: Lu, Liangjian, et al.
Published: (2023) -
Dysregulated T-cell metabolomic profile in patients with steroid-resistant nephrotic syndrome
by: Chan, Chang Yien, et al.
Published: (2021) -
MeSsAGe risk score: tool for renal biopsy decision in steroid-dependent nephrotic syndrome
by: CHAN CHANG YIEN, et al.
Published: (2019) -
Rituximab for the treatment of relapsing-remitting multiple sclerosis in Thailand: an economic evaluation and budget impact analysis
by: Aungsumart S.
Published: (2023)